CollPlant (CLGN) Provides a Corporate Update

Go back to CollPlant (CLGN) Provides a Corporate Update

CollPlant Biotechnologies Provides a Corporate Update

February 12, 2025 6:00 AM UTC

-  Additional patent granted for photocurable dermal filler
-  Update on AbbVie dermal filler program and achievement of contingent payment
-  Plan for cost reductions in place to extend cash runway

REHOVOT, Israel, Feb. 12, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today... More